Nabis Holdings Receives Regulatory Approval to Operate its New Assets, Emerald Phoenix and Infusion Edibles in Arizona
16 Octubre 2019 - 7:15AM
Nabis Holdings Inc. (CSE:NAB) (OTC: NABIF)
(FRA:A2PL) (“NabisTM” or the “Company”), a leading Canadian
investment company with specialty investments in assets across
multiple divisions of the cannabis sector, today announced that it
has received all required regulatory approvals to operate the
assets of Perpetual Healthcare Inc, Emerald Phoenix, a licensed
medical marijuana dispensary located in Phoenix, Arizona and
Infusion Edibles, a popular cannabis infused snack and beverage
brand. The acquisition of these assets was previously announced on
August 12, 2019. Nabis’ portfolio of operating licensing rights has
now increased to a total of 11 for retail, cultivation and
processing facilities combined in 4 states across the U.S.
“As one of the strongest limited-license,
medical cannabis markets in the U.S., Arizona continues to be a
priority market for Nabis. Expanding our operations with the
Emerald Phoenix dispensary and well-known Infusion Edibles brand
better positions us for our next phase of growth. Both businesses
have a wide reach in Arizona, including an active registered
purchasing patient roster of over 12,000 patients at the
dispensary,” said Shay Shnet, CEO & Director of Nabis. “Our
team remains focused on continued expansion as well as the
development of our innovative product lines and brands.”
Nabis’ Arizona operations now include
cultivation, fulfillment, production and retail:
- The Hub, a 44,000 square foot
cultivation, fulfillment and production facility, is located on 2.5
acres of total land and one of the largest industrial warehouses in
the Verde Valley. The Hub is also the new home of production for
WISP pods in Arizona. This is an exclusive production agreement for
the Company.
- Emerald Phoenix, Nabis’ first
operating dispensary licensed to operate in the city of Phoenix
(Maricopa County), which serves more than 133,000 unique patients,
per the Arizona Department of Health Services August 2019
reporting. This dispensary has an active registered purchasing
patient roster of more than 12,000 patients, a healthy marketing
outreach and a loyal word of mouth clientele.
- Infusion Edibles, a highly popular
brand of cannabis infused snacks and beverages. Infusion Edibles’
line of products includes baked goods - brownies and cookies;
candies - gummies and lollies, and soda - root beer and cherry to
name a few flavors. As one of the first medical cannabis kitchens
in Arizona, Infusion Edibles produces superior products with
outstanding flavors, delivering safe, consistent and effective
medication. Under Nabis ownership, the menu will be expanded to
include new products and seasonal treats.
Nabis will acquire 100% of the membership units
of the Asset for total consideration of USD $15 million (CAD $19.65
million) comprised of USD $7 million in cash, $2 million of Nabis’
common stock, and $6 million deferred for 12 months at 5% interest.
The Nabis common stock will be issued in three tranches with each
tranche to be priced based on the ten day volume weighted average
price calculated on the day prior to issuance. Shares issued are
subject to customary regulatory approvals and restrictions.
In connection with the previously announced CFO
and VP Investor Relations appointments, the Company announces that
2 million management incentive stock options have been granted,
pursuant to the terms of the Company's stock option plan. The stock
options are subject to vesting conditions, are priced at $0.10 per
share and expire 5 years after the date of grant.
About Nabis Holdings Inc.Nabis
Holdings is a Canadian investment issuer that invests in high
quality cash flowing assets across multiple industries, including
real property, securities, cryptocurrency, and all aspects of the
U.S. and international cannabis sector. Led by two of the
co-founders of MPX Bioceutical, one of the largest takeovers in the
U.S. Cannabis space to date, the company has a proven track record
in emerging markets to create significant shareholder value. The
Company is focused on investing across the entire vertically
integrated aspects of the space with a focus on revenue generation,
EBITDA and growth.
For more information, please visit
https://www.nabisholdings.com/.
Forward-Looking StatementsAll
statements, other than statements of historical fact, included
herein are forward-looking statements that involve various risks
and uncertainties. There can be no assurance that such statements
will prove to be accurate and actual results and future events
could differ materially from those anticipated in such statements.
The risks are without limitations: that the acquisitions will be
completed by the Company or completed upon the terms disclosed; the
price for cannabis and related products will remain consistent and
the consumer demand remains strong; availability of financing to
the Company to develop the retail locations; retention of key
employees and management; changes in State and/or municipal
regulations of retail operations and changes in government
regulations generally. Important factors that could cause actual
results to differ materially from the Company’s expectations are
disclosed in the Company’s documents filed from time to time with
the Canadian Securities Exchange, the British Columbia Securities
Commission, the Ontario Securities Commission and the Alberta
Securities Commission.
The CSE does not accept responsibility
for the adequacy or accuracy of this release.
For inquiries, please
contact:
Investor Contact:Allison
SossKCSA Strategic Communications PH:
212-896-1267Nabis@kcsa.com
Company Contact:Shay Shnet, CEO
and DirectorPH: 905-581-5521 x107info@nabisholdings.com
Nabis (CSE:NAB)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Nabis (CSE:NAB)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024